ROGER W. JELLIFFE, M.D., F.A.C.P.; JUNE BUELL, B.A.; ROBERT KALABA, PH.D.; R. SRIDHAR, PH.D.; RICHARD ROCKWELL, B.A.; JOHN G. WAGNER, PH.D.
An improved method of digitoxin therapy is presented for adult euthyroid patients of average weight with normal hepatic function, electrolyte balance, and gastrointestinal absorption whose renal function may be normal, reduced, or changing. The method uses a loading dose of 0.8 to 1.4 mg of United States Pharmacopeia (USP) digitoxin in three divided doses 6 hr apart. The proper maintenance dose depends on renal function. Reasonable estimates of it are found from graphs and simple equations presented. In 95% of patients the maintenance dose should sustain body glycoside stores at 73 to 150% of the selected level when renal function is normal and from 73 to 133% in anuric patients. Caution is urged when raising body glycoside stores above 1.4 mg, though this may be necessary to control ventricular rate when atrial arrhythmias are present.
JELLIFFE RW, BUELL J, KALABA R, SRIDHAR R, ROCKWELL R, WAGNER JG. An Improved Method of Digitoxin Therapy. Ann Intern Med. ;72:453–464. doi: 10.7326/0003-4819-72-4-453
Download citation file:
Published: Ann Intern Med. 1970;72(4):453-464.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use